BURLINGTON, Mass., April 12, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer, today announced that Dr. Bobby W. Sandage, Jr., Coronado’s President and CEO, will present at the 19th Annual Future Leaders in the Biotech Industry Conference on Friday, April 20, 2012 at 3:30 PM ET. The conference will be held at the Millennium Broadway Hotel in New York City. A webcast of the presentation will be available at www.coronadobiosciences.com on the Events & Webcasts page.
